From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery - Top-Institutions - MDSpire

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery

  • By

  • Benedette Cuffari

  • May 29, 2026

  • 0 min

Share

Top Institutions in General Medicine

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Pharmacology

  • #2

    Yale University
    Yale University

    New Haven, CT

    Key Differentiators

    • Biomedical Informatics
    • Pharmacology

  • #3

    Emory University
    Emory University

    Atlanta, GA

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    Tufts Center for the Study of Drug Development
    Tufts Center for the Study of Drug Development

    Medford, MA

    Key Differentiators

    • Drug Development
    • Pharmacology

  • #5

    University of Connecticut School of Dental Medicine
    University of Connecticut School of Dental Medicine

    Farmington, CT

    Key Differentiators

    • Dental Medicine
    • Pharmacology

Original Source(s)

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery

  • by Benedette Cuffari

  • May 29, 2026

Related Content

Evaluating the Potential of Reasoning Large Language Models to Perpetuate Racial and Gender Disease Stereotypes in Health Care

Roving Reporter Asks: Where Is Real Progress Being Made in Manufacturing and Supply Chain?

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how automation, AI, closed systems, and smarter supply chain models are helping advanced therapies move toward scalable delivery

  • May 28, 2026

  • 1 min
The Current State and Future of the Digital After Visit Summary—Old Challenges and New Opportunities